TransMedics (TMDX) Amortizatization of Intangibles (2018 - 2022)
TransMedics' (TMDX) quarterly Amortizatization of Intangibles came in at $12000.0 in Q3 2022, down 96.1% year-on-year from $308000.0 in Q3 2021, and down 91.49% quarter-over-quarter from $141000.0 in Q2 2022.
TransMedics (TMDX) Amortizatization of Intangibles (2018 - 2022) Analysis & Trends
TransMedics' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $12000.0 for Q3 2022.
- On a quarterly basis, Amortizatization of Intangibles fell 96.1% year-over-year to $12000.0 in Q3 2022; TTM through Dec 2022 was $381000.0, a 71.9% decrease from a year earlier, with the FY2022 full-year figure at $381000.0, down 71.9% from the prior year.
- Amortizatization of Intangibles declined to $12000.0 in Q3 2022 per TMDX's latest filing, from $141000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $391000.0 in Q1 2021 and bottomed at -$112000.0 in Q3 2019.
- The 5-year median for Amortizatization of Intangibles is $184500.0 (2022), against an average of $157071.4.
- Across the five-year window, Amortizatization of Intangibles jumped 39000.0% in 2021 and tumbled 96.1% in 2022, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $9000.0 in 2018, then plunged by 866.67% to -$69000.0 in 2019, then jumped by 578.26% to $330000.0 in 2020, then decreased by 14.85% to $281000.0 in 2021, then slumped by 95.73% to $12000.0 in 2022.
- Per Business Quant, the three latest TMDX Amortizatization of Intangibles figures stand at $12000.0 (Q3 2022), $141000.0 (Q2 2022), and $228000.0 (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.75 Bn | 180.46 Bn | 6.27 Bn | - |
| 2 | Stryker | 133.49 Bn | 130.61 Bn | 3.81 Bn | - |
| 3 | Medtronic | 112.75 Bn | 103.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.98 Bn | 67.53 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.37 Bn | 45.70 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.90 Bn | 27.78 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.04 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 27.78 Bn | 27.20 Bn | - | - |
| 9 | Koninklijke Philips | 23.24 Bn | 20.20 Bn | 2.01 Bn | - |
| 10 | TransMedics | 2.55 Bn | 2.09 Bn | 101.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 12,000.00 |
| Sep 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 141,000.00 |
| Jun 30, 2022 | 141,000.00 |
| Mar 31, 2022 | 228,000.00 |
| Mar 31, 2022 | 228,000.00 |
| Dec 31, 2021 | 281,000.00 |
| Dec 31, 2021 | 281,000.00 |
| Sep 30, 2021 | 308,000.00 |
| Sep 30, 2021 | 308,000.00 |
| Jun 30, 2021 | 376,000.00 |
| Jun 30, 2021 | 376,000.00 |
| Mar 31, 2021 | 391,000.00 |
| Mar 31, 2021 | 391,000.00 |
| Dec 31, 2020 | 330,000.00 |
| Dec 31, 2020 | 330,000.00 |
| Sep 30, 2020 | 255,000.00 |
| Sep 30, 2020 | 255,000.00 |
| Jun 30, 2020 | 48,000.00 |
| Jun 30, 2020 | 48,000.00 |